Search clinical trials for: Hydroxychloroquine Sulfate 200Mg Tab

Total 286 results

Patrick Hensley

Active, not recruiting

Hydroxychloroquine to Increase Tumor Suppressor PAR-4 Levels in Oligometastatic Prostate Cancer

Prostate Cancer Recurrent

United States
National Institute of Allergy and Infectious Diseases...

Not yet recruiting

CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy

Pregnancy | HIV-1-infection | Postpartum

United States, South Africa
Lionel.D.Lewis, MD
Dartmouth Cancer Center

Not yet recruiting

HCQ in Resectable Localized Prostate Cancer

Resectable Localized Prostate Cancer
Yuhan Corporation

Completed

A Study to Evaluate the Effect of Sarpogrelate on Blood Hyperviscosity

Peripheral Artery Disease, PAD

Korea, Republic of
Peng Wang, MD PhD

Completed

HCQ on PAR-4 Levels in Patients With Resectable Solid Tumors

Solid Tumor

United States
Assistance Publique - Hôpitaux de Paris

Recruiting

New Clinical End-points in Patients With Primary Sjögren's Syndrome (NECESSITY)

Primary Sjögren's Syndrome (pSS)

France
Shaheer A. Khan
AstraZeneca; Melanoma Research Alliance

Completed

Intermittent Selumetinib for Uveal Melanoma

Uveal Melanoma

United States
Tan Tock Seng Hospital
Netherlands: Ministry of Health, Welfare and Sports; Duke-NUS Graduate Medical... and other collaborators

Withdrawn

Safety And Efficacy Of Hydroxychloroquine For At Risk Population (SHARP) Against COVID-19 (SHARP COVID-19)

Coronavirus Infection | Hydroxychloroquine Adverse Reaction
Shaheed Zulfiqar Ali Bhutto Medical University

Unknown

Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19 (CHEER)

COVID 19

Pakistan
dora pereira
University of Oxford; University of Cambridge; Bangor University

Completed

Health Economics of the Use of Ferrous Iron Salts in Primary Care in the UK.

Anemia

United Kingdom
Samyang Biopharmaceuticals Corporation
Severance Hospital

Completed

Crossover Study to Compare Pharmacokinetic Property of SYO-1126 and Glivec Film Coated Tab in Healthy Male Volunteers

Healthy

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/500mg in Healthy Male Volunteers

Diabetes Mellitus, Type II

Korea, Republic of
Shanghai Children's Hospital

Recruiting

Study of Hydroxychloroquine in Patients With X-linked Alport Syndrome in China (CHXLAS) (CHXLAS)

Alport Syndrome, X-Linked

China
Dong Wha Pharmaceutical Co. Ltd.

Completed

Pharmacokinetic Profiles of Metformin With DW1029M (PMD)

Healthy

Korea, Republic of
Children's Hospital of Fudan University

Recruiting

Hydroxychloroquin (HCQ) in chILD of Genetic Defect

Surfactant Dysfunction

China
Azidus Brasil

Completed

Effectiveness of Glucosamine + Chondroitin in Osteoarthrosis

Osteoarthrosis

Brazil
Ravi Amaravadi, MD

Terminated

The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine) (PATCH)

COVID-19

United States
Health Institutes of Turkey

Completed

Clinical Trial For Early SARS-CoV-2 (COVID-19) Treatment

Covid19

Turkey
Radboud University Medical Center
Merck Sharp & Dohme LLC; ZonMw: The Netherlands Organisation for Health Research...

Recruiting

Study on PhArmacokinetics of First liNe Antiretrovirals in Healthy Breastfeeding Volunteers (PANNA-B PK)

Hiv

Netherlands
Genuine Research Center, Egypt
Bio Med for Pharmaceuticals Industries (BIOMED), Egypt

Completed

Bioequivalence Study of Flibanserin From AphroFemine 100 mg F.C.T (Bio Med for Pharmaceuticals Industries (BIOMED), Egypt) Versus Addyi 100 mg Tablets (Sprout Pharmaceuticals, Inc., USA)

Healthy

Egypt
Government of Punjab, Specialized Healthcare and...
Harvard School of Public Health (HSPH); Forman Christian College, Pakistan; Services... and other collaborators

Terminated

Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds (PEACE)

COVID-19 | Coronavirus Infection | SARS-CoV-2 | Asymptomatic Condition

Pakistan
Sandoz

Completed

To Demonstrate the Relative Bioavailability of Hydroxychloroquine Sulfate, 200 mg Tablets

Immunosuppression | Rheumatism
Apsen Farmaceutica S.A.
Federal University of São Paulo

Withdrawn

Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19)

Coronavirus Infections | SARS-CoV 2 | Pulmonary Disease | SARS (Severe Acute Respiratory Syndrome)

Brazil
Universidad Nacional Andres Bello

Completed

Efficacy of Azithromycin as an Adjunct to Non-Surgical Periodontal Treatment

Periodontitis

Chile
Chong Kun Dang Pharmaceutical

Completed

Clinical Trial to Evaluate the Efficacy and Safety of EsoDuo Tab. 20/800mg

Non-erosive Reflux Disease(NERD)

Korea, Republic of
Rutgers, The State University of New Jersey

Terminated

Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19

COVID-19 | SARS-CoV-2

United States
Government of Punjab, Specialized Healthcare and...
Services Hospital, Lahore; Mayo Hospital Lahore; Pakistan Kidney and Liver Institute

Terminated

PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds (PRECISE)

Covid-19 | Sars-CoV2 | Symptomatic Condition

Pakistan
Yuhan Corporation

Completed

Clinical Trial to Evaluate the Efficacy and Safety of Sarpogrelate SR in Patients With Chronic Artery Occlusive Disease

Arterial Occlusive Diseases | Intermittent Claudication

Korea, Republic of
Fundacion Clinic per a la Recerca Biomédica

Active, not recruiting

Switch Strategy From Etravirine (ETR) to Doravirine (DOR) in Virologically-Suppressed HIV-1 Infected Adults With ETR-Resistance

HIV-1-infection

Spain
Bukwang Pharmaceutical

Completed

A Study Comparing the Pharmacokinetics of BK-C-0701 320mg, 480mg and Thiocacid HR Tab 600mg in Healthy Adult Male Subjects

Healthy Adult Male

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

CKD-396 Drug-drug Interaction Study(B) (CKD-396 DDI(B) P1)

Diabetes Mellitus Type 2

Korea, Republic of
Yuhan Corporation

Completed

A Clinical Trial of YH14642 in Patients With Chronic Periodontal Disease (YH14642)

Chronic Periodontitis

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Completed

A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fasting Conditions

Healthy

Korea, Republic of
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Completed

Efficacy and Safety Study of Magnesium Isoglycyrrhizinate Injection in Subjects With Acute Drug-induced Liver Injury

Drug-Induced Liver Injury

China
Chong Kun Dang Pharmaceutical

Completed

Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-393 in Healthy Subjects

Diabetes Mellitus, Type 2

Korea, Republic of
Samyang Biopharmaceuticals Corporation
Seoul National University Hospital

Completed

Study to Compare Pharmacokinetic Property of SYO-1644 Tab. and Nexavar Tab. in Healthy Male Volunteers

Healthy, Male

Korea, Republic of
Assistance Publique - Hôpitaux de Paris

Withdrawn

Acute Rhabdomyolysis and Muscle Pain Associated With Mutations in the LPIN1 Gene - A Retrospective Study Describing the Safety and Efficacy of Hydroxychloroquine Sulfate Given on a Compassionate Basis to Patients Suffering From Lipin-1 Deficiency (LIPIN-1-METAB)

LIPIN1 Deficiency

France
Hackensack Meridian Health

Completed

Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers

Covid19

United States
Peking University First Hospital

Completed

A Study of Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy

Hydroxychloroquine | IgA Patients

China
LLiu

Completed

Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy: a Self- Controlled Study

Primary IgA Nephropathy

China
Hanlim Pharm. Co., Ltd.

Recruiting

Phase 4 Study to Evaluate Efficacy and Safety of Entelon Tab.150mg in Patients With Chronic Venous Disease(CVD)

Chronic Venous Disease

Korea, Republic of
HK inno.N Corporation

Enrolling by invitation

PK, PD and Safety of Tegoprazan 12.5 mg After Oral Administration in Healthy Subjects

Healthy

Korea, Republic of
HK inno.N Corporation

Completed

PK and PD Interaction Between Tegoprazan and NOACs After Multiple Oral Dosing in Healthy Volunteers

Healthy

Korea, Republic of
University Hospital Tuebingen
Universitätsklinikum Hamburg-Eppendorf; Robert Bosch Medical Center; Bernhard...

Terminated

Hydroxychloroquine for COVID-19 (COV-HCQ)

COVID-19, Hydroxychloroquine Sulfate

Germany
Texas Cardiac Arrhythmia Research Foundation

Withdrawn

Prophylactic Benefit of Hydroxychloroquine in COVID-19 Cases With Mild to Moderate Symptoms and in Healthcare Workers With High Exposure Risk (PREVENT)

COVID-19
Qazvin University Of Medical Sciences

Completed

Systemic Zinc Sulphate in Treatment of Recurrent Aphthous Ulcerations:A Doubleblind, Placebo Controled Study

Aphthous Stomatitis

Iran, Islamic Republic of
Onconic Therapeutics Inc.

Completed

Drug-drug Interactions and Safety Among JP-1366, Amoxicillin, and Clarithromycin in Healthy Volunteers

Helicobacter Pylori Associated Gastrointestinal Disease

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Completed

A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Feeding Conditions

Healthy

Korea, Republic of
Second Affiliated Hospital, School of Medicine,...

Recruiting

The Efficacy and Safety of Iguratimod (IGU) in the Treatment of Primary Sjögren's Syndrome

Primary Sjögren's Syndrome

China
Shanghai First Maternity and Infant Hospital
Fudan University; Xinhua Hospital, Shanghai Jiao Tong University School of... and other collaborators

Not yet recruiting

A Study of Hydroxychloroquine Sulfate in the Treatment of Recurrent Spontaneous Abortion With Antiphospholipid Syndrome

Recurrent Miscarriage | Antiphospholipid Syndrome

China

Search clinical trials for: Hydroxychloroquine Sulfate 200Mg Tab

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Estonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations